Atypical fracture risk outweighed by bisphosphonates benefit
The risk of atypical fractures from taking bisphosphonates in people with osteoporosis is low, according to US researchers.
Get unlimited access
As a subscriber you will benefit from:
- Full online and mobile access to news and opinion stories
- Customised email alerts straight to your inbox (30+ alerts available)
- 4,500 practice articles in our archive
- Over £500 worth of CPD learning units